Hedge Funds Weigh In On Ionis Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hedge funds weigh in on ionis pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hedge Funds Weigh In On Ionis Pharmaceuticals Today - Breaking & Trending Today

Ionis Pharmaceuticals (NASDAQ:IONS) Reaches New 1-Year Low at $36.44

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $36.44 and last traded at $36.44, with a volume of 220851 shares traded. The stock had previously closed at $37.64. Analyst Ratings Changes Several equities analysts have recently weighed […] ....

United States , Piper Sandler , Joseph Baroldi , William Blair , Hedge Funds Weigh In On Ionis Pharmaceuticals , News Ratings For Ionis Pharmaceuticals Daily , Ionis Pharmaceuticals , Ionis Pharmaceuticals Stock Down , Mather Group , Sunbelt Securities Inc , Wells Fargo Company , Securities Exchange Commission , Ionis Pharmaceuticals Company Profile , Pingora Partners , Ionis Pharmaceuticals Inc , Get Free Report , Wells Fargo , Pharmaceuticals Stock Down , Director Joseph Klein , Exchange Commission , Valley Asset Management Partners , Sunbelt Securities , Ionis Pharmaceuticals Daily ,

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives $56.08 Average Price Target from Analysts

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives $56.08 Average Price Target from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Joseph Baroldi , William Blair , News Ratings For Ionis Pharmaceuticals Daily , Insider Transactions At Ionis Pharmaceuticals , Hedge Funds Weigh In On Ionis Pharmaceuticals , Jpmorgan Chase Co , Ionis Pharmaceuticals Inc , Wolfe Research , Board Of Administration Florida Retirement System , Ionis Pharmaceuticals Price Performance , Analyst Recommendations For Ionis Pharmaceuticals , Bleakley Financial Group , Blair William Co , Securities Exchange Commission , Ionis Pharmaceuticals , Midwest Professional Planners , Get Free Report , Marketbeat Ratings , Director Joseph Klein , Exchange Commission , Professional Planners , Florida Retirement System , Financial Group , Get Free , Ionis Pharmaceuticals Daily ,

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Average Rating of "Moderate Buy" from Brokerages

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Average Rating of "Moderate Buy" from Brokerages
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Joseph Baroldi , Hedge Funds Weigh In On Ionis Pharmaceuticals , Securities Exchange Commission , Ionis Pharmaceuticals , Needham Company , Wells Fargo Company , Ionis Pharmaceuticals Inc , News Ratings For Ionis Pharmaceuticals Daily , Analyst Recommendations For Ionis Pharmaceuticals , Ionis Pharmaceuticals Stock Down , Mather Group , Royal Bank , Pingora Partners , Peoples Bank , Get Free Report , Wells Fargo , Director Joseph Klein , Exchange Commission , Valley Asset Management Partners , Pharmaceuticals Stock Down , Get Free , Ionis Pharmaceuticals Daily ,

Wells Fargo & Company Trims Ionis Pharmaceuticals (NASDAQ:IONS) Target Price to $82.00

Wells Fargo & Company Trims Ionis Pharmaceuticals (NASDAQ:IONS) Target Price to $82.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Joseph Baroldi , Needham Company , Wells Fargo Company , Ionis Pharmaceuticals , Ionis Pharmaceuticals Inc , Grandfield Dodd , Ionis Pharmaceuticals Company Profile , Fifth Third Bancorp , Ionis Pharmaceuticals Price Performance , Third Bancorp , Securities Exchange Commission , Analyst Recommendations For Ionis Pharmaceuticals , Victory Capital Management Inc , Hedge Funds Weigh In On Ionis Pharmaceuticals , Financial Services Group Inc , Jpmorgan Chase Co , News Ratings For Ionis Pharmaceuticals Daily , Free Report , Wells Fargo , Moderate Buy , Get Free Report , Exchange Commission , Director Joseph Klein , Services Group ,

Oppenheimer Boosts Ionis Pharmaceuticals (NASDAQ:IONS) Price Target to $72.00

Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its price target boosted by Oppenheimer from $65.00 to $72.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has an outperform rating on the stock. A number of other research firms also recently weighed in on IONS. Royal Bank of Canada lifted their price target […] ....

New Zealand General , New Zealand , United States , B Lynne Parshall , William Blair , Piper Sandler , Royal Bank , Pricet Rowe Associates Inc , Securities Exchange Commission , Vanguard Group Inc , Ionis Pharmaceuticals Stock Down , Ionis Pharmaceuticals , Jpmorgan Chase Co , T Rowe Price Investment Management Inc , Wellington Management Group , Ionis Pharmaceuticals Inc , Clearbridge Investments , Analyst Recommendations For Ionis Pharmaceuticals , Hedge Funds Weigh In On Ionis Pharmaceuticals , News Ratings For Ionis Pharmaceuticals Daily , Free Report , Moderate Buy , Pharmaceuticals Stock Down , Get Free Report , Directorb Lynne Parshall , Exchange Commission ,